Genetic Signatures Limited (ASX:GSS)
Australia
· Delayed Price · Currency is AUD 0.4050
-0.0250 (-5.81%)
Apr 30, 2025, 2:04 PM AEST
Genetic Signatures Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 14.66 | 9.77 | 16.94 | 35.42 | 28.28 | 11.26 | Upgrade
|
| Other Revenue | 4 | 4 | 4.57 | 0.08 | 0.1 | 2.55 | Upgrade
|
| Revenue | 18.66 | 13.77 | 21.51 | 35.5 | 28.38 | 13.82 | Upgrade
|
| Revenue Growth (YoY) | 26.86% | -36.00% | -39.39% | 25.06% | 105.43% | 96.71% | Upgrade
|
| Cost of Revenue | 8.73 | 7.91 | 11.83 | 13.6 | 11.25 | 5.51 | Upgrade
|
| Gross Profit | 9.94 | 5.86 | 9.68 | 21.9 | 17.14 | 8.31 | Upgrade
|
| Selling, General & Admin | 20.01 | 19.11 | 19.44 | 14.67 | 12.19 | 8.1 | Upgrade
|
| Other Operating Expenses | 4.42 | 3.09 | 3.31 | 2.58 | 1.99 | 1.6 | Upgrade
|
| Operating Expenses | 26.88 | 24.19 | 24.28 | 18.87 | 15.61 | 10.59 | Upgrade
|
| Operating Income | -16.94 | -18.33 | -14.59 | 3.03 | 1.53 | -2.28 | Upgrade
|
| Interest Expense | -0.08 | -0.04 | -0 | -0.02 | -0.04 | -0.03 | Upgrade
|
| Interest & Investment Income | 1.19 | 0.5 | 0.54 | 0.13 | 0.21 | 0.27 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0.09 | -0.07 | -0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.04 | - | - | 0.01 | 0.13 | 0.09 | Upgrade
|
| EBT Excluding Unusual Items | -15.79 | -17.86 | -14.05 | 3.06 | 1.76 | -2.09 | Upgrade
|
| Asset Writedown | -6.8 | - | - | - | - | - | Upgrade
|
| Pretax Income | -22.59 | -17.86 | -14.05 | 3.06 | 1.76 | -2.09 | Upgrade
|
| Net Income | -22.59 | -17.86 | -14.05 | 3.06 | 1.76 | -2.09 | Upgrade
|
| Net Income to Common | -22.59 | -17.86 | -14.05 | 3.06 | 1.76 | -2.09 | Upgrade
|
| Net Income Growth | - | - | - | 74.43% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 204 | 165 | 143 | 143 | 143 | 127 | Upgrade
|
| Shares Outstanding (Diluted) | 204 | 165 | 143 | 145 | 146 | 127 | Upgrade
|
| Shares Change (YoY) | 42.04% | 15.25% | -1.40% | -0.16% | 14.76% | 22.06% | Upgrade
|
| EPS (Basic) | -0.11 | -0.11 | -0.10 | 0.02 | 0.01 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.11 | -0.11 | -0.10 | 0.02 | 0.01 | -0.02 | Upgrade
|
| EPS Growth | - | - | - | 74.39% | - | - | Upgrade
|
| Free Cash Flow | -12.07 | -12.1 | -14.38 | 8.09 | -0.46 | -11.77 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.07 | -0.10 | 0.06 | -0.00 | -0.09 | Upgrade
|
| Gross Margin | 53.24% | 42.53% | 45.01% | 61.69% | 60.38% | 60.14% | Upgrade
|
| Operating Margin | -90.77% | -133.14% | -67.83% | 8.54% | 5.38% | -16.47% | Upgrade
|
| Profit Margin | -121.06% | -129.74% | -65.32% | 8.63% | 6.19% | -15.10% | Upgrade
|
| Free Cash Flow Margin | -64.67% | -87.88% | -66.86% | 22.80% | -1.61% | -85.18% | Upgrade
|
| EBITDA | -14.91 | -16.53 | -13.07 | 4.3 | 2.56 | -1.7 | Upgrade
|
| EBITDA Margin | -79.89% | -120.05% | -60.74% | 12.12% | 9.02% | -12.30% | Upgrade
|
| D&A For EBITDA | 2.03 | 1.8 | 1.53 | 1.27 | 1.03 | 0.58 | Upgrade
|
| EBIT | -16.94 | -18.33 | -14.59 | 3.03 | 1.53 | -2.28 | Upgrade
|
| EBIT Margin | -90.77% | -133.14% | -67.83% | 8.54% | 5.38% | -16.47% | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.